Table 3.
Significant associations between patient characteristics and gene expression.
| Gene | Covariate | Comparison | Fold change | P-value |
|---|---|---|---|---|
| IMP3 | Cutaneous | Yes vs no | 1.83 | 0.006 |
| PLEKHA7 | Grade | High vs low | 0.35 | 0.023 |
| Vascular endothelial growth factor (VEGF) | Grade | High vs low | 1.98 | 0.028 |
| SAA4 | Cutaneous | Yes vs no | 0.38 | 0.036 |
| SFRP1 | Grade | High vs low | 0.17 | 0.036 |
| MAOB | Grade | High vs low | 0.21 | 0.039 |
| VEGF | Tumor type | Metastases vs primaries | 2.52 | 0.014 |
| Recurrences vs primaries | 1.31 | 0.373 | ||
| IMP3 | Tumor type | Metastases vs primaries | 0.60 | 0.046 |
| Recurrences vs primaries | 1.73 | 0.016 | ||
| TCEA3 | Tumor type | Metastases vs primaries | 5.30 | 0.019 |
| Recurrences vs primaries | 0.99 | 0.982 | ||
| KI-67 | Tumor type | Metastases vs primaries | 0.71 | 0.601 |
| Recurrences vs primaries | 3.47 | 0.036 | ||
| TCN2 | Tumor type | Metastases vs primaries | 1.51 | 0.482 |
| Recurrences vs primaries | 0.35 | 0.045 |